Main Co., Ltd. announced that it participated as a key participant in the "DoctorAnswer 3.0" launch ceremony held on October 1st. This launch ceremony marked the beginning of a next-generation digital healthcare R&D project hosted by the Ministry of Science and ICT, and Main Co., Ltd. will lead the development of Agentic AI for full-cycle maternal health monitoring.
'Doctor Answer 3.0' is a large-scale consortium-based research and development project involving various medical AI companies and medical institutions. It is characterized by an expanded technological scope and clinical applicability compared to existing ones, including precision medicine, AI diagnostic assistance, patient prognosis management, and digital therapeutics linkage.
In this project, Main Co., Ltd. plans to perform the following roles: ▲Planning and developing a personalized maternal prognosis management application and chatbot service ▲Implementing an Agentic AI-based maternal health monitoring system ▲Advancing an integrated AI analysis platform through linkage with medical institutions and third-party solutions ▲Establishing a global expansion strategy based on the SaaS (Software as a Service) model.
This project will be funded with a total budget of 6.3 billion won, including 2.3 billion won from the 2025 main budget and 4 billion won from the second-half supplementary budget. Professor Kim Dae-jin of Seoul St. Mary's Hospital is overseeing the project, with Severance Hospital participating as a co-leading institution. Additionally, 10 medical institutions nationwide, including Seoul Asan Medical Center, Bundang Seoul National University Hospital, and Gachon University Gil Hospital, as well as 16 companies including EasyCareTech, Acryl, AITRIX, and Main Co., Ltd., are participating.
You must be logged in to post a comment.